SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $242,188 | -10.5% | 403,782 | +94.1% | 0.00% | -50.0% |
Q2 2023 | $270,462 | -70.6% | 208,048 | -60.1% | 0.00% | -66.7% |
Q1 2023 | $918,704 | +149.0% | 521,991 | +344.2% | 0.01% | +200.0% |
Q4 2022 | $369,026 | -42.0% | 117,524 | -9.4% | 0.00% | -60.0% |
Q3 2022 | $636,000 | +55.1% | 129,789 | +31.1% | 0.01% | +66.7% |
Q2 2022 | $410,000 | -38.3% | 99,010 | +144.2% | 0.00% | -75.0% |
Q4 2017 | $665,000 | +41.5% | 40,540 | +29.4% | 0.01% | +33.3% |
Q3 2017 | $470,000 | – | 31,340 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |